1. All Products
  2. AS 25mg / AQ eq. 67.5mg base, blister of 3 tab, 4.5-8 kg
Public Pricelist

AS 25mg / AQ eq. 67.5mg base, blister of 3 tab, 4.5-8 kg

https://medicalguidelines.msf.org/en/node/358
https://unicat.msf.org/cat/product/11883
STD DORAASAQ1T1

Valid Article

Former Code(s): -X DORAARAC01-
Article is intended to be used with children (<12 years) ONLY.
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BF03
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ARTESUNATE (AS)/ AMODIAQUINE (AQ)

Therapeutic Action

Fixed-dose combination (FDC) of two antimalarials

Indications

Treatment of uncomplicated P. falciparum malaria

Completion treatment following parenteral therapy for severe malaria

Instructions for use

4 different presentations for 4 categories of weight:

  • infants 4.5-8 kg (2-11 months) : blister of 3 tab. (25/67.5mg)
  • toddlers 9-17 kg (1-5 years): blister of 3 tab. (50/135 mg)
  • children 18-35 kg (6-13 years): blister of 3 tab. (100/270 mg)
  • adults > 36 kg (14 and over): blister of 6 tab. (100/270 mg)

The quantity to be ordered is calculated per blister (= one treatment), not per tablet.

Storage

Below 25°C